Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7273
Rank
C$0.84 B
Marketcap
C$24.01
Share price
-1.40%
Change (1 day)
-51.60%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total assets

Total assets on the balance sheet as of June 2026 : C$0.27 Billion

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total assets are C$0.27 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Avalon Pharma (Middle East Pharmaceutical) - Total assets on balance sheet (from 2023 to 2026)

Total assets by year

Year Total assets Change
2025-12-31C$0.21 B8.73%
2024-12-31C$0.20 B25.66%
2023-12-31C$0.16 B